Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 447

1.

Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.

Gelibter S, Mazzi B, Tassara M, Colombo B, Guerrieri S, Giordano A, Preziosa P, Comola M, Esposito F, Martinelli V, Rocca MA, Comi G, Leocani L, Martinelli-Boneschi F.

Mult Scler Relat Disord. 2018 Jul 24;25:73-76. doi: 10.1016/j.msard.2018.07.017. [Epub ahead of print]

PMID:
30053751
2.

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

Romeo MAL, Martinelli V, Dalla Costa G, Colombo B, De Feo D, Esposito F, Ferrè L, Guaschino C, Guerrieri S, Liberatore G, Martinelli Boneschi F, Merlini A, Messina M, Messina R, Nuara A, Preziosa P, Radaelli M, Rocca MA, Rodegher M, Sangalli F, Strambo D, Moiola L, Comi G.

Acta Neurol Scand. 2018 Nov;138(5):447-453. doi: 10.1111/ane.12999. Epub 2018 Jul 22.

PMID:
30033621
3.

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.

Crisà E, Cilloni D, Elli EM, Martinelli V, Palumbo GA, Pugliese N, Beggiato E, Frairia C, Cerrano M, Lanzarone G, Marchetti M, Mezzabotta M, Boccadoro M, Ferrero D.

Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

PMID:
29984826
4.

Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.

Giordano A, Colombo B, Spinelli EG, Gelibter S, Guerrieri S, Leocani L, Comi G, Martinelli V.

Mult Scler Relat Disord. 2018 Aug;24:69-71. doi: 10.1016/j.msard.2018.06.011. Epub 2018 Jun 20.

PMID:
29957351
5.

Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.

Zacchigna S, Martinelli V, Moimas S, Colliva A, Anzini M, Nordio A, Costa A, Rehman M, Vodret S, Pierro C, Colussi G, Zentilin L, Gutierrez MI, Dirkx E, Long C, Sinagra G, Klatzmann D, Giacca M.

Nat Commun. 2018 Jun 26;9(1):2432. doi: 10.1038/s41467-018-04908-z.

6.

Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.

Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.

Neurol Sci. 2018 Aug;39(8):1467-1470. doi: 10.1007/s10072-018-3440-0. Epub 2018 May 13.

PMID:
29756179
7.

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.

Srinivasan S, Severa M, Rizzo F, Menon R, Brini E, Mechelli R, Martinelli V, Hertzog P, Salvetti M, Furlan R, Martino G, Comi G, Coccia EM, Farina C.

Sci Rep. 2018 May 11;8(1):7615. doi: 10.1038/s41598-018-24987-8.

8.

Depression after a cardiac arrest: An unpredictable issue to always investigate for.

Baldi E, Vanini B, Savastano S, Danza AI, Martinelli V, Politi P.

Resuscitation. 2018 Jun;127:e10-e11. doi: 10.1016/j.resuscitation.2018.03.027. Epub 2018 Mar 16. No abstract available.

PMID:
29555262
9.

Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.

Sorosina M, Clarelli F, Ferrè L, Osiceanu AM, Unal NT, Mascia E, Martinelli V, Comi G, Benigni F, Esposito F, Martinelli Boneschi F.

Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.

PMID:
29528549
10.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
11.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
12.

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.

Esposito F, Ferrè L, Clarelli F, Rocca MA, Sferruzza G, Storelli L, Radaelli M, Sangalli F, Moiola L, Colombo B, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V.

J Neurol. 2018 Apr;265(4):896-905. doi: 10.1007/s00415-018-8791-1. Epub 2018 Feb 12.

PMID:
29435643
13.

Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.

Laurini E, Martinelli V, Lanzicher T, Puzzi L, Borin D, Chen SN, Long CS, Lee P, Mestroni L, Taylor MRG, Sbaizero O, Pricl S.

Cardiovasc Res. 2018 May 1;114(6):846-857. doi: 10.1093/cvr/cvy040.

PMID:
29432544
14.

Changes in quality of life and functional capacity after lung transplantation: A single-center experience.

Ricotti S, Martinelli V, Caspani P, Monteleone S, Petrucci L, Dalla Toffola E, Klersy C.

Monaldi Arch Chest Dis. 2017 Dec 18;87(3):831. doi: 10.4081/monaldi.2017.831.

15.

Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience.

Cerchione C, Nappi D, Pareto AE, Romano A, Martinelli V, Picardi M, Pane F, Catalano L.

Anticancer Drugs. 2018 Apr;29(4):371-372. doi: 10.1097/CAD.0000000000000604.

PMID:
29420336
16.

Digital epidemiology confirms a latitude gradient of MS in France.

Dalla Costa G, Giordano A, Romeo M, Sangalli F, Comi G, Martinelli V.

Mult Scler Relat Disord. 2018 Feb;20:129-131. doi: 10.1016/j.msard.2018.01.009. Epub 2018 Mar 20.

PMID:
29414285
17.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
18.

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.

Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L.

Ann Neurol. 2018 Feb;83(2):283-294. doi: 10.1002/ana.25146. Epub 2018 Feb 15.

19.

Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.

Rocca MA, Riccitelli GC, Meani A, Pagani E, Del Sette P, Martinelli V, Comi G, Falini A, Filippi M.

Mult Scler. 2018 Jan 1:1352458517750767. doi: 10.1177/1352458517750767. [Epub ahead of print]

PMID:
29303036
20.

Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation.

Puzzi L, Borin D, Martinelli V, Mestroni L, Kelsell DP, Sbaizero O.

Micron. 2018 Mar;106:27-33. doi: 10.1016/j.micron.2017.12.005. Epub 2017 Dec 19.

PMID:
29291530

Supplemental Content

Loading ...
Support Center